The division will encompass not only DSM’s own PUFA portfolio but also Martek’s algal DHA omega-3 and ARA omega-6 ingredients.
DSM Nutritional Products (Parsippany, NJ) has created a new division, Nutritional Lipids. Since DSM acquired Martek Biosciences (Columbia, MD) earlier this year, the division will encompass not only DSM’s own polyunsaturated fatty acid (PUFA) portfolio but also Martek’s algal docosahexaenoic acid (DHA) omega-3 and arachidonic acid (ARA) omega-6 ingredients. According to DSM, the umbrella of offerings makes it the world’s “leading innovator and supplier in this category.”
“The nutritional lipids category of health and nutrition ingredients is science-based, fast growing, and in an early stage of development, with significant growth opportunities,” the company stated in a press release.
Peter A Nitze, who joined Martek in 2005 and was COO at the time of its acquisition by DSM, will lead the new Nutritional Lipids division as president. Steve Dubin, Martek’s CEO at the time of its acquisition, will be taking on a new role at DSM, which is yet to be announced. David Abramson, Martek’s president at the time of acquisition, is now senior executive advisor for DSM Nutritional Products.